-70.3%
ENPH vs BBIO
+154.4%
-224.7%
-81.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.4% | -0.1% | -1.3% | -1.4% |
| 7D | -0.1% | -3.2% | +3.2% | +0.8% |
| 30D | -10.8% | -13.6% | +2.8% | -7.2% |
| 3M | -33.8% | +7.2% | -41.1% | -35.5% |
| 6M | -16.1% | +1.5% | -17.6% | -17.3% |
| YTD | +13.4% | -5.3% | +18.7% | +12.9% |
| 1Y | -2.6% | +37.7% | -40.3% | -14.4% |
| 3Y | -70.3% | +153.9% | -224.2% | -80.7% |
| All | -70.3% | +154.4% | -224.7% | -80.7% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling